Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
J Perinatol. 2010 Jul;30(7):459-68. doi: 10.1038/jp.2009.186. Epub 2009 Dec 31.
To identify a risk profile for harmful medication errors in the neonatal intensive care unit (NICU).
A retrospective cross-sectional study on NICU medication error reports submitted to MEDMARX between 1 January 1999, and 31 December 2005. The Rao-Scott modified chi(2) test was used for analysis.
6749 NICU medication error reports were submitted by 163 health-care facilities. Administering errors accounted for approximately one half of errors, and human factors were the most frequently cited cause of error. Patient age was not associated with an increased likelihood of an error being harmful (P=0.11). Error reports involving Institute for Safe Medication Practices (ISMP) High-Alert Medications, occurring in the prescribing phase of medication processing, or involving equipment/delivery device failures were more likely to be harmful (P< or =0.05).
Risk factors for harmful medication error reports include use of ISMP High-Alert Medications, the prescribing phase of the medication use process, and failure of equipment/delivery devices.
确定新生儿重症监护病房(NICU)中有害药物错误的风险特征。
对 1999 年 1 月 1 日至 2005 年 12 月 31 日期间向 MEDMARX 提交的 NICU 药物错误报告进行的回顾性横断面研究。采用 Rao-Scott 修正卡方检验进行分析。
163 家医疗机构共提交了 6749 份 NICU 药物错误报告。给药错误约占一半,人为因素是错误最常被引用的原因。患者年龄与发生有害错误的可能性增加无关(P=0.11)。涉及安全用药实践研究所(ISMP)高危药物、发生在药物处理的开处方阶段或涉及设备/输送装置故障的错误报告更有可能是有害的(P<或=0.05)。
有害药物错误报告的危险因素包括使用 ISMP 高危药物、药物使用过程的开处方阶段以及设备/输送装置故障。